NCT06447519

Brief Summary

The aim of the study is to evaluate the effectiveness of calcium hydroxide as an intracanal medicament in the clinical and radiographic healing of periapical tissues in teeth diagnosed with symptomatic apical periodontitis. This evaluation will be conducted after multiple visit endodontic treatment. The follow-up sessions will be programmed from 6 to 24 months postoperatively. Postoperative pain will also be considered as a secondary outcome. Participants will be asked to rate their pain level on a numerical scale from 0 to10 before and after each session of endodontic treatment. Additionally, the use of analgesics after the procedure will be measured and the incidence of flare-ups will be evaluated. Two study groups will be formed to undergo multiple-visit endodontic treatment. The intervention group will receive intracanal medication of calcium hydroxide, while the control group will have the root canal left empty between appointments.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
110

participants targeted

Target at P50-P75 for not_applicable

Timeline
4mo left

Started Sep 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress83%
Sep 2024Sep 2026

First Submitted

Initial submission to the registry

May 27, 2024

Completed
11 days until next milestone

First Posted

Study publicly available on registry

June 7, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

September 12, 2024

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 12, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 12, 2026

Last Updated

February 10, 2026

Status Verified

February 1, 2026

Enrollment Period

2 years

First QC Date

May 27, 2024

Last Update Submit

February 9, 2026

Conditions

Keywords

Multivisit Endodontic TreatmentInterapointment dressingApical PeriodontitisOutcome

Outcome Measures

Primary Outcomes (2)

  • Clinical evidence of success

    Criteria of clinical success include the absence of pain and tenderness to palpation and percussion and the absence of sinus or any associated soft tissue swelling. Failure is indicated by the presence of at least one of the abovementioned signs or symptoms.

    6-24 months post-operatively

  • Radiographic evidence of success

    Radiographic evidence of periapical healing will be evaluated by the improvement of Periapical Index score (PAI). The PAI system provides an ordinal scale of 5 scores ranging from 1 (healthy) to 5 ( severe periodontitis with exacerbating features). In detail PAI score 1 indicates normal periapical anatomy. PAI score 2 indicates mild changes in bone pattern. PAI score 3 is indicative by changes in bone pattern with diffuse loss of mineral. PAI score 4 is indicative of apical periodontitis with definite radiolucency in the periapical area. PAI score 5 indicates severe periodontitis with exacerbating features. Improvement of PAI score will be evaluated as success. Consequently a lower PAI score is indicative of success but a higher or stable PAI score is indicative of failure.

    6-24 months post-operatively

Secondary Outcomes (2)

  • Flare-up incidence

    0 to 3 days after every single appointment

  • Postoperative pain assesment

    0 to 3 days after every single appointment

Study Arms (2)

Ca(OH)2 intracanal medicament

EXPERIMENTAL

Ca(OH)2 intracanal medicament used for root canal disinfection as interapointment dressing.

Drug: Ca(OH)2 as intracanal medicament

Standard of Care

NO INTERVENTION

No intracanal medicament. The root canal will be left empty without any intracanal dressing between appointments.

Interventions

Ca(OH2 will be used as intracanal medicament for the disinfection of the root canal between appointmnents

Ca(OH)2 intracanal medicament

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ASA grade: I or II
  • Age: ≥18 years
  • Permanent teeth
  • Pulp diagnosis: necrosis or previously treated
  • Diagnosis of periapical tissues: symptomatic apical periodontitis
  • Teeth sensitive to percussion and/or palpation
  • Initial PAI: 3-5
  • Signed Patient Consent Statement for participation in clinical research

You may not qualify if:

  • Pregnant women
  • Patients who receive corticosteroids and/or have received antibiotics within the previous three months
  • Patients who report pain in a different area than that of the tooth under investigation
  • Teeth that cannot be isolated with a rubber dam
  • Teeth with extensive hard tissue destruction that is not restorable
  • Teeth with an anatomic peculiarity of the root canal (internal resorption, perforation, displacement of root canal course due to previous endodontic treatment)
  • Teeth in which the formation of the apex has not been completed
  • Fractured teeth with periodontal involvement
  • Teeth with periodontal pocket depth ≥ 4mm or teeth with bone loss at the bifurcation of the roots due to periodontitis
  • Teeth with loss of periodontal attachment ≥ 5 mm
  • Teeth with embedded exudate in the session planned for root canal obturation.
  • Teeth that after completion of the endodontic treatment show underocclusion \>2mm or hyperobstruction \>1mm from the radiographic apex.
  • Teeth in which permanent restoration has not been completed over time less than one month after endodontic treatment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

School of Dentitry, Aristotle University of Thessaloniki

Thessaloniki, Central Macedonia, 54124, Greece

RECRUITING

Related Publications (4)

  • Weiger R, Rosendahl R, Lost C. Influence of calcium hydroxide intracanal dressings on the prognosis of teeth with endodontically induced periapical lesions. Int Endod J. 2000 May;33(3):219-26. doi: 10.1046/j.1365-2591.1999.00298.x.

    PMID: 11307438BACKGROUND
  • Paredes-Vieyra J, Enriquez FJ. Success rate of single- versus two-visit root canal treatment of teeth with apical periodontitis: a randomized controlled trial. J Endod. 2012 Sep;38(9):1164-9. doi: 10.1016/j.joen.2012.05.021. Epub 2012 Jul 26.

    PMID: 22892729BACKGROUND
  • Mergoni G, Ganim M, Lodi G, Figini L, Gagliani M, Manfredi M. Single versus multiple visits for endodontic treatment of permanent teeth. Cochrane Database Syst Rev. 2022 Dec 13;12(12):CD005296. doi: 10.1002/14651858.CD005296.pub4.

    PMID: 36512807BACKGROUND
  • Rossi-Fedele G, Rodig T. Effectiveness of root canal irrigation and dressing for the treatment of apical periodontitis: A systematic review and meta-analysis of clinical trials. Int Endod J. 2023 Oct;56 Suppl 3:422-435. doi: 10.1111/iej.13777. Epub 2022 May 31.

    PMID: 35579074BACKGROUND

MeSH Terms

Conditions

Tooth, NonvitalPeriapical Periodontitis

Condition Hierarchy (Ancestors)

Dental Pulp DiseasesTooth DiseasesStomatognathic DiseasesPeriapical DiseasesJaw DiseasesPeriodontal DiseasesMouth DiseasesPeriodontitis

Study Officials

  • Nikolaos Economides, Prof.

    School of Dentistry, Aristotle University of Thessaloniki

    STUDY DIRECTOR

Central Study Contacts

Konstantinos Kodonas, Ass.Prof.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 27, 2024

First Posted

June 7, 2024

Study Start

September 12, 2024

Primary Completion (Estimated)

September 12, 2026

Study Completion (Estimated)

September 12, 2026

Last Updated

February 10, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Available IPD Datasets

Study Protocol Access

Locations